Posted on 10/10/2020 9:54:50 AM PDT by libh8er
Edited on 10/10/2020 10:10:15 AM PDT by Admin Moderator. [history]
Blood samples from three patients here were used to develop the experimental antibody cocktail used to treat US President Donald Trump after he tested positive for the coronavirus.
The National Centre for Infectious Diseases (NCID) had responded to a collaboration request from US biotechnology firm Regeneron - the company which developed that antibody cocktail - with no claim of intellectual property right over the treatment.
(Excerpt) Read more at straitstimes.com ...
Very interesting. I wonder why Regeneron went to Singapore to get three of the antibody samples. Couldn’t they have gotten them in the US?
Reports of antibody treatments in the works emerged in June, with most of them in labs across Asia, including Singapore, Japan, China and South Korea. .....
For Singapore, its defence research and development organisation DSO National Laboratories had announced in June that it had discovered five antibodies that could block the coronavirus and protect against key mutations, after scientists screened hundreds of thousands of cells that produce the antibodies
Apparently the selection process for antibodies to use as a starting point is rigorous and some Asian labs were further ahead in their research at the time. My guess is for advantages of time they went with what was already available.
Look for Trump to start speaking Mandarin...
If he does, maybe even fluently, it will only be for a short while because antibodies clear out after a few months.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.